Dissemination plans
The results of this study will be disclosed unreservedly at the end of the study. Results that are important for public health will be notified to the competent authorities as soon as possible (RIVM, WMO). The trial will be registered in a public trial registry before the first patient is consented. A description of this clinical trial will be available on 